Health-Related Quality of Life for Persons Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (AMC-A01)

Treatment arm participants experienced significant worsening in physical symptoms and impact on psychological functioning from T1-T2 but returned to prerandomization levels by T3, indicating that any immediate anal HSIL treatment-related impacts to HRQoL are temporary. Further research is needed to determine long-term impacts of anal HSIL treatment on HRQoL.

Authors

Institutions

Publication Details

Journal
JCO Oncology Practice
Published
2025-03-06
DOI
https://doi.org/10.1200/op-24-00830
Primary Topic
Colorectal and Anal Carcinomas
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Health-Related Quality of Life for Persons Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (AMC-A01)

Shireesha Dhanireddy, Dorothy J. Wiley, Stephen E. Goldstone, Luis F. Barroso et al.
JCO Oncology Practice
Colorectal and Anal Carcinomas
article

Health-Related Quality of Life for Persons Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (AMC-A01)

Shireesha Dhanireddy, Dorothy J. Wiley, Stephen E. Goldstone, Luis F. Barroso, Julia C. Pugliese, Timothy Wilkin, Mark H. Einstein, Hillary Dunlevy, Erica I. Lubetkin, David F Cella, Susan Holland, Jessica D. Korman, Jeannette Y. Lee, Grant Ellsworth, Benjamin Stearn, David M. Aboulafia, Thomas M. Atkinson, Madhu Mazumdar, Gary Bucher, Edward M. Gardner, Joel M. Palefsky, Elizabeth A. Stier, Kathleen Lynch, J. Michael Berry-Lawhorn, Ronald T. Mitsuyasu, Grace Van Hyfte, Yuelin Li, Andrew Webb, Isabella Rosa-Cunha, Rebecca Levine, Jeffrey T. Schouten
article en

Abstract

Treatment arm participants experienced significant worsening in physical symptoms and impact on psychological functioning from T1-T2 but returned to prerandomization levels by T3, indicating that any immediate anal HSIL treatment-related impacts to HRQoL are temporary. Further research is needed to determine long-term impacts of anal HSIL treatment on HRQoL.

JCO Oncology PracticeVol. 21(10)
Northwestern University (US), Atrium Health Wake Forest Baptist (US), University of Colorado Hospital (US), APLA Health (US), Virginia Mason Medical Center (US), Memorial Sloan Kettering Cancer Center (US), Montefiore Medical Center (US), University of Miami (US), University of California, Los Angeles (US), University of California, San Francisco (US), Cornell University (US), CUNY School of Law (US), Denver Health Medical Center (US), Harborview Medical Center (US), University of California San Diego (US), Denver Public Health (US), Public Health Institute (US), Midwest Orthopaedic Research Foundation (US), Weill Cornell Medicine (US), New York University (US), University of Arkansas for Medical Sciences (US), University of Colorado Denver (US), Icahn School of Medicine at Mount Sinai (US)
Openalex Percentile: Top 93%
Colorectal and Anal Carcinomas
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.